CSPC PHARMACEUT.GR. ADR4 (CVGU) — Financial Flexibility Index

Latest as of December 2025: 0.67x

CSPC PHARMACEUT.GR. ADR4 (CVGU) has a Financial Flexibility Index of 0.67x as of December 2025. Free cash flow of €8.11 Billion (operating CF €5.83 Billion minus capex €2.28 Billion) represents 1% of total liabilities (€12.15 Billion). Also explore net asset momentum of CSPC PHARMACEUT.GR. ADR4 to track the company's year-over-year net asset growth rate.

Financial Flexibility Index

0.67x
Free Cash Flow / Total Liabilities

Free Cash Flow

€8.11 Billion
Operating CF − Capex

Total Liabilities

€12.15 Billion
EUR

Capital Expenditures

€2.28 Billion
EUR

CSPC PHARMACEUT.GR. ADR4 Financial Flexibility Index (2021–2025)

Historical Financial Flexibility Index trend for CSPC PHARMACEUT.GR. ADR4 across 5 annual periods. Check CSPC PHARMACEUT.GR. ADR4 liquid asset ratio to evaluate the company's liquid asset resilience ratio.

Annual Financial Flexibility Index for CSPC PHARMACEUT.GR. ADR4 (2021–2025)

Year-by-year free cash flow to debt coverage for CSPC PHARMACEUT.GR. ADR4. For the full company profile including market capitalisation, see CVGU stock market capitalisation.

Year Flexibility Index Free Cash Flow (EUR) Operating CF Total Liabilities YoY Change
2025 0.67x €8.11 Billion €5.83 Billion €12.15 Billion ▼ -2.6%
2024 0.69x €7.21 Billion €4.53 Billion €10.52 Billion ▲ +27.2%
2023 0.54x €6.07 Billion €4.18 Billion €11.26 Billion ▼ -47.3%
2022 1.02x €10.35 Billion €7.63 Billion €10.13 Billion ▲ +26.5%
2021 0.81x €6.40 Billion €4.64 Billion €7.91 Billion
Financial Flexibility Index = (Operating CF − Capex) / Total Liabilities = Free Cash Flow / Total Liabilities